Key Takeaways
- • Ben Narasin, Founder and General Partner at Tenacity Venture Capital, discussed his venture investing philosophy and journey in a full CNBC interview, emphasizing evidence-based approaches to early-stage investing.
- • Tenacity Venture Capital operates with a focus on seed-stage investments, with Narasin directing equity efforts through TriplePoint Ventures, a wholly owned subsidiary of TriplePoint Capital.
- • Narasin critiques the "spray and pray" approach to venture investing, advocating instead for disciplined, data-driven investment strategies in the seed and early-stage funding landscape.
- • The interview covers Narasin's career trajectory from early entrepreneurial ventures through his evolution as a venture capital operator managing significant portfolio commitments.
Summary
Ben Narasin, Founder and General Partner at Tenacity Venture Capital, appeared in a comprehensive CNBC interview to discuss his approach to venture capital investing and his perspective on the evolution of seed-stage funding dynamics. Narasin brings substantial operational experience to the venture capital space, having built his career around early-stage company development and investor-founder relationships.
Through his leadership at Tenacity Venture Capital and his direction of equity efforts at TriplePoint Ventures—a wholly owned subsidiary of TriplePoint Capital—Narasin has positioned himself at the intersection of seed-stage investing and later-round capital deployment. His firm maintains a focused investment thesis centered on early-stage companies, representing a deliberate concentration of effort in what is often considered the highest-risk segment of the venture funding continuum.
A central theme of Narasin's interview centers on challenging prevailing industry practices, particularly what he terms the "spray and pray" methodology in venture investing. This critique reflects a broader institutional conversation about capital allocation efficiency: rather than diversifying across numerous small bets with minimal due diligence, Narasin advocates for disciplined, evidence-based investment decision-making. This philosophical stance mirrors growing pressure within the venture capital industry to demonstrate measurable returns and accountability to limited partners.
The CNBC interview provides institutional investors, hedge fund managers, and family offices insight into how established venture practitioners view current market conditions and future opportunities in early-stage capital deployment. Narasin's perspective on portfolio construction, founder evaluation, and risk management serves as a valuable reference point for alternative investment professionals evaluating their own venture capital allocations and investment processes.
Through his leadership at Tenacity Venture Capital and his direction of equity efforts at TriplePoint Ventures—a wholly owned subsidiary of TriplePoint Capital—Narasin has positioned himself at the intersection of seed-stage investing and later-round capital deployment. His firm maintains a focused investment thesis centered on early-stage companies, representing a deliberate concentration of effort in what is often considered the highest-risk segment of the venture funding continuum.
A central theme of Narasin's interview centers on challenging prevailing industry practices, particularly what he terms the "spray and pray" methodology in venture investing. This critique reflects a broader institutional conversation about capital allocation efficiency: rather than diversifying across numerous small bets with minimal due diligence, Narasin advocates for disciplined, evidence-based investment decision-making. This philosophical stance mirrors growing pressure within the venture capital industry to demonstrate measurable returns and accountability to limited partners.
The CNBC interview provides institutional investors, hedge fund managers, and family offices insight into how established venture practitioners view current market conditions and future opportunities in early-stage capital deployment. Narasin's perspective on portfolio construction, founder evaluation, and risk management serves as a valuable reference point for alternative investment professionals evaluating their own venture capital allocations and investment processes.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.